RNAZ
TransCode Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenNov 2, 2026 11:06:30 AM EST
1.65USD+1.227%(+0.02)7,385
Loading…
Loading…
27.94M
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$1.66
Beta
1.03
52-Week High
$12.60 2026-01-26
52-Week Low
$1.52 2026-10-01
SMA 50
$1.83
SMA 200
$6.15
Avg. Vol 10D
26,425
Avg. Vol 30D
46,614
Avg. Vol 90D
46,673
Relative Vol
0.15
16.93M
965,708
5.70%
54,968
5.69%
1.36
43%/57%
28.82%
20.37%
9.0400%
80,000
3,289
2,658
11,172
Nov 13, 2026 (11d)
May 15, 2025 · 1-for-28 (reverse)
-42.8M
-51.18
397.59
Oct 28, 2026
TransCode Therapeutics explores strategic alternatives · 
Investing.com
Oct 19, 2026
Oct 1, 2026
Sep 22, 2026
RNAZ Profile
transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.
RNAZ Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.71 | 2026-10-26 | -3.25% | 2.827 |
| 1M | 1.57 | 2026-10-02 | +5.10% | 2.213 |
| 3M | 4.22 | 2026-08-03 | -60.90% | 2.867 |
| 6M | 7.83 | 2026-05-01 | -78.93% | 1.461 |
| 1Y | 10.51 | 2025-11-03 | -84.30% | 1.030 |
| 2Y | 443.52 | 2024-11-01 | -99.63% | — |
| 5Y | 2,402,400.00 | 2021-11-02 | -100.00% | 0.203 |
RNAZ Stock Summary
TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $1.65, and today's volume is 7,185. RNAZ is up 1.227% today. The 30 day average volume is 46,614. RNAZ market cap is $27.94M with 16.93M shares outstanding.